Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Receivables (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Change in Receivables for 6 consecutive years, with -$197000.0 as the latest value for Q2 2025.

  • Quarterly Change in Receivables fell 211.93% to -$197000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$197000.0 through Jun 2025, down 211.93% year-over-year, with the annual reading at -$197000.0 for FY2025, 211.93% down from the prior year.
  • Change in Receivables hit -$197000.0 in Q2 2025 for Benitec Biopharma, down from $226000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $226000.0 in Q1 2025 to a low of -$226000.0 in Q3 2024.
  • Historically, Change in Receivables has averaged -$2750.0 across 4 years, with a median of $0.0 in 2021.
  • Biggest YoY gain for Change in Receivables was 757.14% in 2022; the steepest drop was 771.43% in 2022.
  • Year by year, Change in Receivables stood at -$7000.0 in 2021, then surged by 757.14% to $46000.0 in 2022, then plummeted by 591.3% to -$226000.0 in 2024, then increased by 12.83% to -$197000.0 in 2025.
  • Business Quant data shows Change in Receivables for BNTC at -$197000.0 in Q2 2025, $226000.0 in Q1 2025, and -$226000.0 in Q3 2024.